Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The obese older female patient: CV risk and the SCOUT study

International Journal of Obesity volume 31, pages S26–S30 (2007)Cite this article

Abstract

Cardiovascular disease is a major killer in women yet is frequently considered a male-dominated disease. The risk of cardiovascular disease in women is frequently underestimated and there is also considerable evidence of a treatment bias against women. Women are generally underrepresented in cardiovascular clinical trials yet there is evidence of gender-specific differences in the responses to pharmacotherapy. The Sibutramine Cardiovascular Outcomes (SCOUT) trial has been designed to determine whether weight management with sibutramine together with a diet- and exercise-based lifestyle intervention can prevent cardiovascular morbidity and mortality in high-risk overweight and obese patients. The SCOUT population includes a large number of older women, at high risk for cardiovascular disease. Data from the trial's lead-in phase indicate that treatment with sibutramine and lifestyle management for 6 weeks result in clinically important weight loss and reduction in waist circumference. Despite an initial lower body weight, older women with cardiovascular disease and diabetes mellitus appear to lose as much weight as men. In the overall SCOUT population, treatment with sibutramine is associated with small median decreases in systolic and diastolic blood pressure and small median increases in pulse rate. The side-effect profile of sibutramine in this older, ‘at-risk’ population was similar to that previously observed in younger patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. World Health Organization Statistical Information System 2004. www.who.int/whosis/.

  2. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006; 27: 994–1005.

    Article  Google Scholar 

  3. Bello N, Mosca L . Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 2004; 46: 287–295.

    Article  Google Scholar 

  4. Herlitz J, Starke M, Hansson E, Ringvall E, Karlson BW, Waagstein L . Characteristics and outcome among women and men transported by ambulance due to symptoms arousing suspicion of acute coronary syndrome. Med Sci Monit 2002; 8: CR251–CR256.

    PubMed  Google Scholar 

  5. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293–1304.

    Article  CAS  Google Scholar 

  6. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322.

    Article  Google Scholar 

  7. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM . Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217–225.

    Article  CAS  Google Scholar 

  8. Maynard C, Litwin PE, Martin JS, Weaver WD . Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152: 972–976.

    Article  CAS  Google Scholar 

  9. Wong Y, Rodwell A, Dawkins S, Livesey SA, Simpson IA . Sex differences in investigation results and treatment in subjects referred for investigation of chest pain. Heart 2001; 85: 149–152.

    Article  CAS  Google Scholar 

  10. Gregor RD, Bata IR, Eastwood BJ, Garner JB, Guernsey JR, MacKenzie BR et al. Gender differences in the presentation, treatment, and short-term mortality of acute chest pain. Clin Invest Med 1994; 17: 551–562.

    CAS  PubMed  Google Scholar 

  11. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A . Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001; 322: 832.

    Article  CAS  Google Scholar 

  12. Fleury J, Keller C, Murdaugh C . Social and contextual etiology of coronary heart disease in women. J Womens Health Gend Based Med 2000; 9: 967–978.

    Article  CAS  Google Scholar 

  13. Clarke KW, Gray D, Keating NA, Hampton JR . Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309: 563–566.

    Article  CAS  Google Scholar 

  14. Alter DA, Naylor CD, Austin P, Tu JV . Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999; 341: 1359–1367.

    Article  CAS  Google Scholar 

  15. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: iii–iv, 1–182.

    Article  CAS  Google Scholar 

  16. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.

    Article  CAS  Google Scholar 

  17. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.

    Article  CAS  Google Scholar 

  18. Knoops KT, de Groot LC, Kromhout D, Perrin A, Moreiras-Varela O, Menotti A et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292: 1433–1439.

    Article  Google Scholar 

  19. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C . Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am J Epidemiol 1995; 141: 1128–1141.

    Article  CAS  Google Scholar 

  20. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T . Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499–1504.

    Article  CAS  Google Scholar 

  21. Padwal R, Li SK, Lau DC . Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2004; 3: CD004094.

    Google Scholar 

  22. James WPT . The SCOUT study: risk–benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J Suppl 2005; 7 (Suppl 7): L44–L48.

    Article  CAS  Google Scholar 

  23. Torp-Pedersen C, Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni AP et al. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J 2007: [e-pub ahead of print, doi: 10.1093/eurheartj/ehm217].

    Article  Google Scholar 

  24. Van Gaal L, Caterson I, Coutinho W, Finer N, Maggioni AP, Sharma AM et al. Endocrinol Metabol Nutr 2006; 15: 270. Abstract CO 30.

Download references

Author information

Authors and Affiliations

  1. Obesity & Eating Disorders Research Group, Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil

    W F Coutinho

Authors
  1. W F Coutinho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W F Coutinho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coutinho, W. The obese older female patient: CV risk and the SCOUT study. Int J Obes 31 (Suppl 2), S26–S30 (2007). https://doi.org/10.1038/sj.ijo.0803733

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803733

Keywords

Search

Advanced search

Quick links